Arrowhead Pharmaceuticals Statistics
NASDAQ: ARWRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
41.37-2.28 (-5.22%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arrowhead Pharmaceuticals by the numbers
Arrowhead Pharmaceuticals has a market capitalization of $5.85 billion based on 141.37M shares outstanding. With trailing EPS of $-5.11, Arrowhead Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 41.3% below its 200-day average.
Average daily trading volume is 2.08M shares, or about $86.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARWR valuation vs. peer median
| Metric | ARWR | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.85B | $5.64B | +4% |
| Avg. volume | 2.08M | 715.37K | +191% |
Peer median across 8 companies: SUPN, LGND, GRFS, MIRM, ABVX, BLTE, MANE, LQDA.
Valuation
- Market cap
- $5.85B
- Price / sales (latest FY)
- 12.97
- EPS (TTM)
- $-5.11
- Shares outstanding
- 141.37M
Price and trading
- Previous close
- 43.65
- Open
- 43.42
- Day range
- 41.17 – 44.80
- 52-week range
- 40.43 – 95.49
- 52-week change
- +2.27%
- Beta
- —
- Volume
- 3.91M
- Average volume
- 2.08M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 24, 2026
Additional statistics
- Market Cap
- 5.85B
- Forward Pe
- -11.79
- Eps
- -5.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 95.49
- Week52 Low
- 40.43
- Avg Volume
- 2.08M
- Shares Outstanding
- 141.37M
- Ma50
- 59.24
- Ma200
- 70.43
- Earnings Date
- Nov 24, 2026
- Pct From52w High
- -56.68%
- Pct From52w Low
- 2.33%